Commission Implementing Regulation (EU) 2018/917 of 27 June 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, carvone, chlorpropham, cyazofamid, desmedipham, dimethoate, dimethomorph, diquat, ethephon, ethoprophos, etoxazole, famoxadone, fenamidone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, Gliocladium catenulatum strain: J1446, isoxaflutole, metalaxyl-m, methiocarb, methoxyfenozide, metribuzin, milbemectin, oxasulfuron, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, pymetrozine and s-metolachlor
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
069/2019 In force in the EEA
Yes Legal documents
Commission Implementing Regulation (EU) 2018/917 of 27 June 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, carvone, chlorpropham, cyazofamid, desmedipham, dimethoate, dimethomorph, diquat, ethephon, ethoprophos, etoxazole, famoxadone, fenamidone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, Gliocladium catenulatum strain: J1446, isoxaflutole, metalaxyl-m, methiocarb, methoxyfenozide, metribuzin, milbemectin, oxasulfuron, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, pymetrozine and s-metolachlor
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2018/917 frá 27. júní 2018 um breytingu á framkvæmdarreglugerð (ESB) nr. 540/2011 að því er varðar framlengingu á samþykkistímabilum fyrir virku efnin alfasýpermetrín, beflúbútamíð, benalaxýl, benþíavalíkarb, bífenasat, boskalíð, brómóoxýníl, kaptan, karvón, klórprófam, sýasófamíð, desmedífam, dímetóat, dímetómorf, díkvat, etefón, etóprófos, etoxasól, famoxadón, fenamídón, fenamífos, flúmíoxasín, flúoxastróbín, fólpet, foramsúlfúrón, formetanat, Gliocladium catenulatum af stofni J1446, ísoxaflútól, metalaxýl-m, metíókarb, metoxýfenósíð, metríbúsín, milbemektín, oxasúlfúrón, Paecilomyces lilacinus, stofn 251, fenmedífam, fosmet, pírimífosmetýl, própamókarb, próþíókónasól, pýmetrósín og s-metólaklór
Durchführungsverordnung (EU) 2018/917 der Kommission vom 27. Juni 2018 zur Änderung der Durchführungsverordnung (EU) Nr. 540/2011 hinsichtlich der Verlängerung der Laufzeit der Genehmigung für die Wirkstoffe Alpha-Cypermethrin, Beflubutamid, Benalaxyl, Benthiavalicarb, Bifenazat, Boscalid, Bromoxynil, Captan, Carvon, Chlorpropham, Cyazofamid, Desmedipham, Dimethoat, Dimethomorph, Diquat, Ethephon, Ethoprophos, Etoxazol, Famoxadon, Fenamidon, Fenamiphos, Flumioxazin, Fluoxastrobin, Folpet, Foramsulfuron, Formetanat, Gliocladium catenulatum Stamm: J1446, Isoxaflutol, Metalaxyl-M, Methiocarb, Methoxyfenozid, Metribuzin, Milbemectin, Oxasulfuron, Paecilomyces lilacinus Stamm 251, Phenmedipham, Phosmet, Pirimiphos-methyl, Propamocarb, Prothioconazol, Pymetrozin und S-Metolachlor
Kommisjonens gjennomføringsforordning (EU) 2018/917 av 27. juni 2018 om endring av gjennomføringsforordning (EU) nr. 540/2011 med hensyn til forlengelse av godkjenningsperioden for de aktive stoffene alfa-cypermetrin, beflubutamid, benalaksyl, bentiavalikarb, bifenazat, boskalid, bromoksynil, kaptan, karvon, klorprofam, cyazofamid, desmedifam, dimetoat, dimetomorf, dikvat, etefon, etoprofos, etoksazol, famoksadon, fenamidon, fenamifos, flumioksazin, fluoksastrobin, folpet, foramsulfuron, formetanat, Gliocladium catenulatum stamme: J1446, isoksaflutol, metalaksyl-m, metiokarb, metoksyfenozid, metribuzin, milbemektin, oksasulfuron, Paecilomyces lilacinus stamme 251, fenmedifam, fosmet, pirimifos-metyl, propamokarb, protiokonazol, pymetrozin og s-metolaklor
History
30.03.2019
Adopted JCD confirmed entry into force date
30.03.2019
Compliance date in the EEA
29.03.2019
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
16.01.2019
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
27.06.2018
Adoption date in the EU
29.06.2018
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.